finally ACR is green, good for a change.
Where on earth is all the news that is due??? FDA re Elanco product is now well overdue, details of any windfall resulting from VIVUS breach ($1m anyone?), details of plans re Evamist etc etc.
Any case the sub $1.90 dip was a good buying op. Only problem is now we have to cycle through the good selling op post $2. Say the average buy lately has been $1.90 I think $2.10 will now be a hurdle.
But surely by the end of the year we have to be close to $3, if you're not in by the time Axiron is confirmed (if it is!) you won't get a bite of that $200m.
We should see a slow and steady leap frog effect with bottom feeders/rampers cycling the stock, skimming %10 at every opportunity and creating a headwind for ACR, but she's a tough one and will push on up to $3 by Feb '11.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.548M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 351996 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 16.21pm 08/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable